What is the primary objective of **SOC 2**?

**The primary objective of SOC 2 is to provide independent assurance that a service organization's controls meet the Trust Services Criteria (TSC) for security, availability, processing integrity, confidentiality, and privacy.** Developed by the AICPA, SOC 2 evaluates systems handling customer data, with Security (CC1-CC9) as the mandatory common criteria. Type 2 reports assess design and operating effectiveness over 3-12 months, delivering stakeholder trust for SaaS and cloud providers.

Who is legally or professionally required to comply with **SOC 2**?

**No organization is legally required to comply with SOC 2, as it is a voluntary AICPA framework, but service organizations are professionally compelled by enterprise client mandates.** It targets SaaS, cloud, fintech, and data processors storing or transmitting customer data, especially those pursuing deals with annual contract values over $5,000. Fortune 500 vendors demand Type 2 reports in RFPs and MSAs, disqualifying non-compliant providers.

Does **SOC 2** require an external audit or third-party certification?

**Yes, SOC 2 requires an external audit by an independent AICPA-accredited CPA firm to issue Type 1 or Type 2 attestation reports.** Type 1 verifies control design at a point in time; Type 2 tests operating effectiveness over 3-12 months via sampling, walkthroughs, and evidence review. No formal "certification" exists—reports provide the assurance, with unqualified opinions signaling compliance.

How often should an assessment for **SOC 2** be performed?

**SOC 2 Type 2 assessments should be performed annually, covering a 3-12 month monitoring period to demonstrate ongoing operating effectiveness.** Bridge letters from management extend validity up to 3 months between audits. Continuous monitoring, quarterly access reviews, and annual penetration tests sustain controls, with recertification bridging prior and new periods for uninterrupted assurance.

What are the consequences of non-compliance with **SOC 2**?

**Non-compliance with SOC 2 results in lost enterprise deals, extended sales cycles by 3-6 months, and heightened breach liability, though no direct AICPA fines apply.** Clients reject vendors lacking Type 2 reports in VRM processes, inflating CAC by 20-50%. Breaches without documented TSC controls trigger SLA penalties, litigation exceeding $1M, and reputational damage delaying funding.

Can **SOC 2** be mapped to other international frameworks?

**Yes, SOC 2 controls map extensively to frameworks like ISO 27001 (80% overlap), NIST CSF, and others via AICPA spreadsheets.** Common Criteria (CC1-CC9) align with ISO Annex A controls, enabling reuse for multi-compliance. This reduces duplication for global SaaS firms, with Security TSC serving as a baseline for GDPR or HIPAA integrations without separate audits.

What is the first step to begin implementing **SOC 2**?

**The first step to implement SOC 2 is a scoping exercise and gap analysis against the Trust Services Criteria, engaging a CPA auditor for readiness assessment.** Define in-scope systems, data flows, and TSC (Security mandatory, plus optionals like Availability). Inventory assets, map 50-100 controls, and prioritize remediation using tools like Vanta for evidence automation.

What is the primary objective of **FDA 21 CFR Part 11**?

**The primary objective of FDA 21 CFR Part 11 is to establish criteria under which the Agency considers electronic records and electronic signatures trustworthy, reliable, and equivalent to paper records and handwritten signatures (§11.1(a)).** This equivalency enables electronic methods while ensuring authenticity, integrity, confidentiality (when appropriate), and non-repudiation through controls like validation (§11.10(a)), access limitation (§11.10(d)), audit trails (§11.10(e)), and electronic signature requirements (§§11.50–11.300).

Who is legally or professionally required to comply with **FDA 21 CFR Part 11**?

**FDA 21 CFR Part 11 applies to organizations using electronic records created, modified, maintained, archived, retrieved, or transmitted under predicate rules, or submitted electronically to FDA (§11.1(b)).** It targets life sciences firms (pharma, biotech, devices) relying on electronic records in lieu of paper for regulated activities, or where electronic versions are relied upon even if paper exists; exclusions apply to certain food records (§11.1(f)–(p)) and paper records transmitted electronically.

Does **FDA 21 CFR Part 11** require an external audit or third-party certification?

**No, FDA 21 CFR Part 11 does not require external audits or third-party certification.** Compliance is demonstrated through internal controls, validation, SOPs, and inspection readiness (§11.1(e)); FDA verifies during inspections via systems, records, and documentation. The 2003 guidance emphasizes risk-based approaches without mandating certifications.

How often should an assessment for **FDA 21 CFR Part 11** be performed?

**FDA 21 CFR Part 11 does not prescribe a fixed frequency for assessments; they must occur via change control, periodic reviews, and risk-based validation lifecycles.** Ongoing evaluation aligns with predicate rules, system changes (§11.10(k)), and operational checks (§11.10(f)); FDA recommends documenting scope/reliance decisions in SOPs with reassessment triggers like upgrades or process shifts.

What are the consequences of non-compliance with **FDA 21 CFR Part 11**?

**Non-compliance with FDA 21 CFR Part 11 can result in FDA enforcement actions including Form 483 observations, warning letters, product holds, recalls, and fines under predicate rules.** While the 2003 guidance exercises discretion on some elements (validation, audit trails), enforced controls (access, signatures) and predicate violations trigger actions; data integrity failures often lead to CGMP citations.

Can **FDA 21 CFR Part 11** be mapped to other international frameworks?

**Yes, FDA 21 CFR Part 11 control objectives for electronic records and signatures can be mapped to frameworks like EU Annex 11, though no formal harmonization exists in the regulation.** Shared principles include risk-based validation, audit trails, access controls, and signature non-repudiation; mappings require documented equivalence for global operations.

What is the first step to begin implementing **FDA 21 CFR Part 11**?

**The first step to implement FDA 21 CFR Part 11 is to establish a formal applicability framework mapping predicate rules to records and assessing business reliance on electronic versions.** Document scope decisions (closed/open systems, §11.3) in SOPs per 2003 guidance to avoid over/under-scoping, prioritizing high-risk records for controls.

SOC 2 vs FDA 21 CFR Part 11

Standards Comparison

SOC 2

Voluntary

2010

AICPA framework for Trust Services Criteria controls

FDA 21 CFR Part 11

Mandatory

1997

FDA regulation for electronic records and signatures equivalence.

Quick Verdict

SOC 2 provides voluntary trust assurance for service providers via TSC audits, accelerating enterprise sales. FDA 21 CFR Part 11 mandates controls for life sciences' electronic records/signatures to ensure data integrity, avoiding regulatory enforcement and enabling paperless operations.

Cybersecurity / Trust

SOC 2

System and Organization Controls 2

Cost

€€€€

Complexity

High

Implementation Time

6-12 months

Key Features

Trust Services Criteria with mandatory Security focus
Type 2 reports validate operating effectiveness over time
Independent AICPA CPA firm attestation
Flexible scoping for service organizations
Overlaps 80% with ISO 27001 HIPAA

Electronic Records

FDA 21 CFR Part 11

21 CFR Part 11 Electronic Records; Electronic Signatures

Cost

€€€€

Complexity

High

Implementation Time

12-18 months

Key Features

Risk-based validation of computerized systems
Secure, time-stamped audit trails for changes
Controls for closed and open systems
Unique multi-component electronic signatures
Signature manifestation and record linking

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

SOC 2 Details

What It Is

SOC 2 (System and Organization Controls 2) is a voluntary attestation framework developed by the AICPA for service organizations. It evaluates controls relevant to Trust Services Criteria (TSC)—security, availability, processing integrity, confidentiality, and privacy—using a risk-based, principles-focused approach. Reports include Type 1 (point-in-time design) and Type 2 (operating effectiveness over 3-12 months).

Key Components

Mandatory Security (CC1-CC9 common criteria) plus optional TSC.
50-100 controls covering access (CC6), monitoring (CC4), risk assessment (CC3).
Built on COSO principles; CPA-led audits with sampling and evidence review.
Annual recertification with bridge letters for continuity.

Why Organizations Use It

Unlocks enterprise deals by streamlining vendor due diligence.
Mitigates breach risks, enhances resilience (99.99% uptime).
Builds trust with stakeholders, accelerates sales 15-30%.
Competitive moat for SaaS/cloud; overlaps ISO 27001, HIPAA, NIST.

Implementation Overview

Phased: scoping/gap analysis (4-8 weeks), deployment/monitoring (3-6 months), audit.
Targets SaaS, fintech, cloud providers; scalable via automation (Vanta, Drata).
Budget $20-100K; suits startups to enterprises in complex environments.

FDA 21 CFR Part 11 Details

What It Is

FDA 21 CFR Part 11 is a U.S. federal regulation establishing criteria for electronic records and electronic signatures to be considered trustworthy, reliable, and equivalent to paper records and handwritten signatures. It applies to FDA-regulated industries using electronic systems for predicate-rule-required records, employing a risk-based approach per FDA's 2003 guidance, with enforcement discretion on some elements like validation while enforcing core controls.

Key Components

**Subpart AScope, implementation, definitions.
**Subpart BControls for closed/open systems (§11.10, §11.30), signature manifestation/linking (§11.50, §11.70).
**Subpart CElectronic signature requirements (§11.100–11.300). Core principles include validation, audit trails, access controls, and ALCOA+ data integrity; no formal certification, but compliance via inspection readiness.

Why Organizations Use It

Meets predicate rule obligations in pharma, devices, biotech.
Mitigates enforcement risks (warnings, holds).
Enables paperless operations, improves efficiency, data integrity.
Builds regulator, partner trust.

Implementation Overview

Phased: scoping, gap analysis, validation (IQ/OQ/PQ), SOPs/training. Targets life sciences; risk-based for all sizes; audited via FDA inspections.

Key Differences

Aspect	SOC 2	FDA 21 CFR Part 11
Scope	Trust Services Criteria: security, availability, confidentiality, etc.	Electronic records/signatures trustworthiness and equivalence to paper
Industry	Service organizations (SaaS, cloud, fintech) all sizes	Life sciences (pharma, devices, biotech) using electronic records
Nature	Voluntary AICPA audit framework	Mandatory FDA regulation with enforcement discretion
Testing	Type 1/2 audits by CPA firms, annual Type 2	Risk-based system validation (IQ/OQ/PQ), ongoing monitoring
Penalties	Market disqualification, lost deals, no legal fines	Warning letters, product holds, fines up to $10K/violation

Scope

SOC 2

Trust Services Criteria: security, availability, confidentiality, etc.

FDA 21 CFR Part 11

Electronic records/signatures trustworthiness and equivalence to paper

Industry

SOC 2

Service organizations (SaaS, cloud, fintech) all sizes

FDA 21 CFR Part 11

Life sciences (pharma, devices, biotech) using electronic records

Nature

SOC 2

Voluntary AICPA audit framework

FDA 21 CFR Part 11

Mandatory FDA regulation with enforcement discretion

Testing

SOC 2

Type 1/2 audits by CPA firms, annual Type 2

FDA 21 CFR Part 11

Risk-based system validation (IQ/OQ/PQ), ongoing monitoring

Penalties

SOC 2

Market disqualification, lost deals, no legal fines

FDA 21 CFR Part 11

Warning letters, product holds, fines up to $10K/violation

Frequently Asked Questions

Common questions about SOC 2 and FDA 21 CFR Part 11

SOC 2 FAQ

FDA 21 CFR Part 11 FAQ

You Might also be Interested in These Articles...

CIS Controls v8.1 IG1 Ransomware-Resilience Sprint: A 30-60-90 Day Action Plan (With Evidence Checklist)

Tactical CIS Controls v8.1 IG1 playbook for ransomware resilience. 30-60-90 day sprint with tool-agnostic tasks, ownership & evidence checklists to prove progre

Asset-Backed Issuers and SEC Cybersecurity Rules: Applicability, Disclosures, and Compliance Roadmap

How SEC cybersecurity rules apply to asset-backed issuers (ABS): Form 10-D disclosures, ABS-EE risk management, Inline XBRL tagging, exemptions. Roadmap for tru

NIST SP 800-53 Rev 5.1 Private Sector Tailoring Blueprint: First 5 Steps to Overlay-Driven Compliance with Infographic

Step-by-step blueprint for private sector NIST SP 800-53 Rev 5.1 tailoring using overlays for AI & supply chain risks. Infographic + first 5 steps for ROI-drive

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Check out these other Gradum.io Standards Comparison Pages

PRINCE2 vs ISO 17025

Compare PRINCE2 vs ISO 17025: PRINCE2 excels in structured project governance with 7 principles for controlled delivery, while ISO 17025 ensures lab competence & impartiality. Unlock key differences & choose wisely.

FDA 21 CFR Part 11 vs GLBA

Discover FDA 21 CFR Part 11 vs GLBA: Key differences in electronic records, signatures & data safeguards. Unlock risk-based compliance strategies for FDA-regulated firms. Achieve audit readiness now.

NIST CSF vs ISO 45001

Compare NIST CSF vs ISO 45001: Cyber risk mastery meets OH&S leadership. Uncover structures, key differences & integration for resilient enterprise risk mgmt. Explore now!

SOC 2

FDA 21 CFR Part 11

Quick Verdict

SOC 2

Key Features

FDA 21 CFR Part 11

Key Features

Detailed Analysis

SOC 2 Details

What It Is

Key Components

Why Organizations Use It

Implementation Overview

FDA 21 CFR Part 11 Details

What It Is

Key Components

Why Organizations Use It

Implementation Overview

Key Differences

Scope

Industry

Nature

Testing

Penalties

Frequently Asked Questions

SOC 2 FAQ

What is the primary objective of SOC 2?

Who is legally or professionally required to comply with SOC 2?

Does SOC 2 require an external audit or third-party certification?

How often should an assessment for SOC 2 be performed?

What are the consequences of non-compliance with SOC 2?

Can SOC 2 be mapped to other international frameworks?

What is the first step to begin implementing SOC 2?

FDA 21 CFR Part 11 FAQ

What is the primary objective of FDA 21 CFR Part 11?

Who is legally or professionally required to comply with FDA 21 CFR Part 11?

Does FDA 21 CFR Part 11 require an external audit or third-party certification?

How often should an assessment for FDA 21 CFR Part 11 be performed?

What are the consequences of non-compliance with FDA 21 CFR Part 11?

Can FDA 21 CFR Part 11 be mapped to other international frameworks?

What is the first step to begin implementing FDA 21 CFR Part 11?

You Might also be Interested in These Articles...

CIS Controls v8.1 IG1 Ransomware-Resilience Sprint: A 30-60-90 Day Action Plan (With Evidence Checklist)

Asset-Backed Issuers and SEC Cybersecurity Rules: Applicability, Disclosures, and Compliance Roadmap

NIST SP 800-53 Rev 5.1 Private Sector Tailoring Blueprint: First 5 Steps to Overlay-Driven Compliance with Infographic

Run Maturity Assessments with GRADUM

Check out these other Gradum.io Standards Comparison Pages

PRINCE2 vs ISO 17025

FDA 21 CFR Part 11 vs GLBA

NIST CSF vs ISO 45001